Employer with a benefit plan ยท SEC filer
CELLDEX THERAPEUTICS, INC.
Also filed as AVANT IMMUNOTHERAPEUTICS INC; T CELL SCIENCES INC
160 GOULD STREET, NEEDHAM, MA 02494
EIN
13-3191702
SEC CIK
0000744218
SEC · 2026-08-14
Industry (SIC)
In Vitro & In Vivo Diagnostic Substances (2835)
SEC · 2026-08-14
State of incorporation
DE
SEC · 2026-08-14
Ticker
CLDX
SEC · 2026-08-14
Latest SEC filing
SCHEDULE 13G/A 2026-08-14
SEC · 2026-08-14
Benefit plan 1, 2024 filing
CELLDEX THERAPEUTICS, INC. EMPLOYEE SAVINGS PLAN
DOL · 2025-07-21
Participants (start of year)
282
DOL · 2025-07-21
Plan features
code 2G2J2K2T3D2F
DOL · 2025-07-21
Plan type
Single-employer plan
DOL · 2025-07-21
Business code (NAICS)
325410
DOL · 2025-07-21
Benefit plan 501, 2024 filing
CELLDEX THERAPEUTICS, INC. WELFARE BENEFIT PLAN
DOL · 2025-06-25
Participants (start of year)
160
DOL · 2025-06-25
Plan features
code 4A4B4D4E4F4H4L4Q
DOL · 2025-06-25
Plan type
Single-employer plan
DOL · 2025-06-25